Schizophrenia as a Specific Biologic Disease
Abstract
Previous work from the Tulane laboratories showed that a psychosis-inducing gamma globulin fraction in sera of schizophrenic patients, designated taraxein, was demonstrable by passive transfer in volunteer nonpsychotic recipients and in rhesus monkeys. In this study the authors found that the presence of taraxein in the sera of schizophrenic patients is specifically related to acute psychotic episodes and that serum fractions of patients with psychotic symptoms from diseases other than schizophrenia produced negative results. They conclude that taraxein is specifically related to schizophrenia.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
